Low-γ-GT-familial-intrahepatic-cholestasis: Difference between revisions

From WikiMD's Wellness Encyclopedia

Admin (talk | contribs)
No edit summary
 
CSV import
 
Line 1: Line 1:
, see '''[[Progressive-familial-intrahepatic-cholestasis
{{Infobox medical condition
{{geneticstub}}
| name          = Low-γ-GT familial intrahepatic cholestasis
| synonyms      =
| image        =
| caption      =
| pronounce    =
| specialty    = [[Hepatology]], [[Pediatrics]]
| symptoms      = [[Jaundice]], [[Pruritus]], [[Steatorrhea]]
| complications = [[Cirrhosis]], [[Liver failure]]
| onset        = Infancy or early childhood
| duration      = Long-term
| types        =
| causes        = Genetic mutations
| risks        = Family history of liver disease
| diagnosis    = [[Liver function tests]], genetic testing
| differential  = [[Progressive familial intrahepatic cholestasis]], [[Alagille syndrome]], [[Biliary atresia]]
| prevention    =
| treatment    = [[Ursodeoxycholic acid]], liver transplantation
| medication    =
| prognosis    = Variable
| frequency    = Rare
| deaths        =
}}
 
'''Low-γ-GT familial intrahepatic cholestasis''' is a rare genetic disorder characterized by impaired bile formation and transport within the liver, leading to [[cholestasis]] without elevated gamma-glutamyltransferase (γ-GT) levels. This condition is one of several types of familial intrahepatic cholestasis, and it primarily affects infants and young children.
 
==Symptoms and Signs==
The primary symptoms of Low-γ-GT familial intrahepatic cholestasis include [[jaundice]] (yellowing of the skin and eyes), [[pruritus]] (itching), and [[steatorrhea]] (fatty stools). These symptoms result from the accumulation of bile acids in the liver and bloodstream, which can also lead to fat-soluble vitamin deficiencies.
 
==Causes==
The disorder is caused by mutations in genes involved in bile acid transport and secretion. The specific genes implicated vary among affected individuals, but mutations lead to dysfunction in the bile salt export pump (BSEP) or other components of the bile secretion pathway.
 
==Diagnosis==
Diagnosis of Low-γ-GT familial intrahepatic cholestasis is based on clinical evaluation, biochemical tests showing normal or low levels of γ-GT in the presence of cholestasis, and the exclusion of other causes of liver disease. Genetic testing can confirm the diagnosis by identifying mutations in the relevant genes.
 
==Treatment==
Treatment options are limited. [[Ursodeoxycholic acid]] may be used to improve bile flow and relieve symptoms. In severe cases, liver transplantation may be considered. Management also includes supportive care such as vitamin supplementation and nutritional support.
 
==Prognosis==
The prognosis for individuals with Low-γ-GT familial intrahepatic cholestasis varies. Some may experience mild symptoms and have a normal life expectancy, while others may develop serious complications like [[cirrhosis]] and [[liver failure]].
 
==See also==
* [[Cholestasis]]
* [[Liver transplantation]]
* [[Genetic testing]]
 
[[Category:Hepatology]]
[[Category:Genetic disorders]]
[[Category:Liver diseases]]
[[Category:Pediatrics]]
 
{{medicine-stub}}

Latest revision as of 20:43, 7 August 2024

Low-γ-GT familial intrahepatic cholestasis
Synonyms
Pronounce
Specialty Hepatology, Pediatrics
Symptoms Jaundice, Pruritus, Steatorrhea
Complications Cirrhosis, Liver failure
Onset Infancy or early childhood
Duration Long-term
Types
Causes Genetic mutations
Risks Family history of liver disease
Diagnosis Liver function tests, genetic testing
Differential diagnosis Progressive familial intrahepatic cholestasis, Alagille syndrome, Biliary atresia
Prevention
Treatment Ursodeoxycholic acid, liver transplantation
Medication
Prognosis Variable
Frequency Rare
Deaths


Low-γ-GT familial intrahepatic cholestasis is a rare genetic disorder characterized by impaired bile formation and transport within the liver, leading to cholestasis without elevated gamma-glutamyltransferase (γ-GT) levels. This condition is one of several types of familial intrahepatic cholestasis, and it primarily affects infants and young children.

Symptoms and Signs[edit]

The primary symptoms of Low-γ-GT familial intrahepatic cholestasis include jaundice (yellowing of the skin and eyes), pruritus (itching), and steatorrhea (fatty stools). These symptoms result from the accumulation of bile acids in the liver and bloodstream, which can also lead to fat-soluble vitamin deficiencies.

Causes[edit]

The disorder is caused by mutations in genes involved in bile acid transport and secretion. The specific genes implicated vary among affected individuals, but mutations lead to dysfunction in the bile salt export pump (BSEP) or other components of the bile secretion pathway.

Diagnosis[edit]

Diagnosis of Low-γ-GT familial intrahepatic cholestasis is based on clinical evaluation, biochemical tests showing normal or low levels of γ-GT in the presence of cholestasis, and the exclusion of other causes of liver disease. Genetic testing can confirm the diagnosis by identifying mutations in the relevant genes.

Treatment[edit]

Treatment options are limited. Ursodeoxycholic acid may be used to improve bile flow and relieve symptoms. In severe cases, liver transplantation may be considered. Management also includes supportive care such as vitamin supplementation and nutritional support.

Prognosis[edit]

The prognosis for individuals with Low-γ-GT familial intrahepatic cholestasis varies. Some may experience mild symptoms and have a normal life expectancy, while others may develop serious complications like cirrhosis and liver failure.

See also[edit]


Stub icon
   This article is a medical stub. You can help WikiMD by expanding it!